BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11724305)

  • 21. Inhibition of epigallocatechin gallate-induced apoptosis by CoCl2 in human oral tumor cell lines.
    Ishino A; Kusama K; Watanabe S; Sakagami H
    Anticancer Res; 1999; 19(6B):5197-201. PubMed ID: 10697534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells.
    Noda C; He J; Takano T; Tanaka C; Kondo T; Tohyama K; Yamamura H; Tohyama Y
    Biochem Biophys Res Commun; 2007 Nov; 362(4):951-7. PubMed ID: 17803956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
    Kim CY; Lee C; Park GH; Jang JH
    Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination effect of lignin F and natural products.
    Jiang Y; Satoh K; Aratsu C; Kobayashi N; Unten S; Kakuta H; Kikuchi H; Nishikawa H; Ochiai K; Sakagami H
    Anticancer Res; 2001; 21(2A):965-70. PubMed ID: 11396189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
    Sadava D; Whitlock E; Kane SE
    Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction between two antioxidants, sodium ascorbate and gallic acid: radical intensity and apoptosis induction.
    Sakagami H; Satoh K
    Anticancer Res; 1996; 16(3A):1231-4. PubMed ID: 8702242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.
    Baatout S; Jacquet P; Derradji H; Ooms D; Michaux A; Mergeay M
    Oncol Rep; 2004 Jul; 12(1):159-67. PubMed ID: 15201978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species.
    Li W; Nie S; Yu Q; Xie M
    J Agric Food Chem; 2009 Aug; 57(15):6685-91. PubMed ID: 19601628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells.
    Qanungo S; Das M; Haldar S; Basu A
    Carcinogenesis; 2005 May; 26(5):958-67. PubMed ID: 15705601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyphenol (-)-epigallocatechin gallate inhibits apoptosis induced by irradiation in human HaCaT keratinocytes.
    Kondo H; Park SH; Watanabe K; Yamamoto Y; Akashi M
    Biochem Biophys Res Commun; 2004 Mar; 316(1):59-64. PubMed ID: 15003511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radical intensity and cytotoxic activity of curcumin and gallic acid.
    Nogaki A; Satoh K; Iwasaka K; Takano H; Takahama M; Ida Y; Sakagami H
    Anticancer Res; 1998; 18(5A):3487-91. PubMed ID: 9858929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.
    Basu A; Haldar S
    Int J Oncol; 2009 Jan; 34(1):281-6. PubMed ID: 19082499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
    Paul B; Hayes CS; Kim A; Athar M; Gilmour SK
    Carcinogenesis; 2005 Jan; 26(1):119-24. PubMed ID: 15375010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin gallate affects human dendritic cell differentiation and maturation.
    Yoneyama S; Kawai K; Tsuno NH; Okaji Y; Asakage M; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
    J Allergy Clin Immunol; 2008 Jan; 121(1):209-14. PubMed ID: 17935769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo.
    Nakazato T; Ito K; Miyakawa Y; Kinjo K; Yamada T; Hozumi N; Ikeda Y; Kizaki M
    Haematologica; 2005 Mar; 90(3):317-25. PubMed ID: 15749663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells.
    Lee JH; Song DK; Jung CH; Shin DH; Park J; Kwon TK; Jang BC; Mun KC; Kim SP; Suh SI; Bae JH
    Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):530-6. PubMed ID: 15298546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.